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Abstract: In common with most viruses, measles virus (MV) relies on the integrity of the 
cytoskeleton of its host cells both with regard to efficient replication in these cells, but also 
retention of their motility which favors viral dissemination. It is, however, the surface 
interaction of the viral glycoprotein (gp) complex with receptors present on lymphocytes 
and dendritic cells (DCs), that signals effective initiation of host cell cytoskeletal 
dynamics. For DCs, these may act to regulate processes as diverse as viral uptake and 
sorting, but also the ability of these cells to successfully establish and maintain functional 
immune synapses (IS) with T cells. In T cells, MV signaling causes actin cytoskeletal 
paralysis associated with a loss of polarization, adhesion and motility, which has been 
linked to activation of sphingomyelinases and subsequent accumulation of membrane 
ceramides. MV modulation of both DC and T cell cytoskeletal dynamics may be important 
for the understanding of MV immunosuppression at the cellular level.  
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1. Introduction  
Measles virus (MV) is the type species of the genus morbillivirus, which are members of the 
paramyxoviridae. Its replication is confined to humans and—mainly experimentally—to non-human 
primates, while it is prevented in murine cells due to type I interferons and their effector proteins and 
OPEN ACCESS 
Viruses 2011, 3              
 
 
103 
other unknown determinants [1]. In humans, the highly infectious MV causes a well known disease in 
unprotected hosts, usually contracted early in childhood, which is self-limiting and leaves the 
individual with a life-long protective immunity. Concurrent with efficient virus-specific immune 
activation, MV causes a generalized, transient immunosuppression allowing for secondary infections 
to occur and to follow a severe or even lethal course; thereby, constituting the major cause of measles 
associated infant mortality. Hallmarks of MV-induced immunosuppression are leukopenia affecting 
most, if not all, peripheral blood mononuclear cell compartments and the inability of lymphocytes to 
expand in response to activation ex vivo [2]. Because the frequency of MV-infected peripheral blood 
cells is very low (not exceeding 2% at any stage of the disease) [3,4], bystander effects of infected 
cells on uninfected cells are thought to be major components of lymphocyte inhibition. The model 
facets, which are investigated from different angles in many laboratories, predict that MV abrogates T 
cell activation at the level of antigen presenting cell (APC)/T cell communication, also including the 
ability of these cells to establish functional immune synapses (IS).  
2. The Role of the Cytoskeleton in MV Uptake and Replication 
For host entry, MV crosses the respiratory epithelium, and for this, infects tissue resident 
professional APCs (e.g., dendritic cells (DCs) or macrophages) rather than epithelial cells. 
Subsequently, MV accesses secondary lymphatic tissues via infected APCs, where efficient replication 
along with transmission to lymphocytes occurs, essentially enabling viral dissemination to the 
reticulo-endothelial system and lymphatic tissues [3,5–7]. Tissue distribution in the hematopoietic 
system and pathogenesis of wild-type MV infection in vivo segregates well with the expression pattern 
of its entry receptor CD150 (also referred to as signaling lymphocyte activation molecule, SLAM), a 
member of the Ig family, which is confined to cells of the hematopoietic lineage [8,9]. Attenuated or 
laboratory adapted MV strains can additionally use CD46, a member of the complement regulator 
family, to which they bind with higher affinity in vitro [10,11]. To what extent interaction with this 
molecule, which is ubiquitously expressed on all nucleated human cells, determines tissue distribution 
in vivo has not yet been established. CD150 and CD46 also recruit signaling complexes, which 
regulate both activation of T cells and the polarity of the T cell response [8,12].  
In addition to these characterized entry receptors, wild-type MV interacts and can use other, as yet 
uncharacterized, receptors to enter endothelial, epithelial and neuronal cells [13–16], while molecules 
such as substance P receptor or moesin may aid rather than directly promote MV entry [17]. Obviously 
confined to APCs, DC-SIGN (DC-specific Intercellular adhesion molecule-3-Grabbing Non-integrin) 
interaction enhances, but does not mediate MV uptake into DCs, and signals in response to MV. This 
is also true for Toll like receptor 2 (TLR2) on monocytes and may play an important role in monocyte 
activation along with CD150 upregulation on these cells [18,19]. These interactions all involve the MV 
hemagglutinin (H) gp alone (for attachment) or in combination with the fusion (F) gp (for entry), 
which, together as the MV gp complex, also elicit signaling in lymphocytes in a contact dependent 
manner (see below). In addition, ligation of the Fc receptor on B cells and an unknown receptor on 
lymphocytes by the MV nucleocapsid (N) protein, modulates antibody production, viability or 
proliferation of target cells (all summarized in Figure 1) [20,21].  
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Figure 1. Cellular surface molecules interacting with measles virus (MV). Surface 
receptors may interact with different MV protein or protein complexes, yet only CD46 and 
CD150 support MV entry. This may be enhanced by substance P receptor interaction, and, 
on dendritic cells (DCs), by DC-SIGN which, as TLR2, promotes APC activation on MV 
binding by relaying signals. Signaling by CD46 and CD150, which can act as CD3  
co-stimulators, has mainly been investigated on antibody ligation and has not yet been 
directly addressed to occur after MV interaction. Signaling via recX and FcR by MV has 
been directly linked to inhibition of lympho/monocytic expansion and/or function.  
 
 
While at least some of the MV receptor interactions outlined above were clearly linked to 
modulation of cytoskeletal dynamics (which will be detailed below), little is generally known on the 
role of the cytoskeleton in MV uptake. The role of cytoskeletal dynamics in MV entry has not yet been 
analyzed. It is, thus, unknown whether MV attachment and entry involves actin-dependent 
translocation of trapping molecules along filopodial structures as revealed for HIV, or if clustering of 
entry receptors (especially CD150, see below) might be required. The impact of actin depolymerizing 
compounds on viral entry has not been studied as yet. MV gp signaling causes moesin and cofilin 
dephosphorylation on binding to T lymphocytes [22], which promotes actin remodeling, and this has 
been suggested to enhance microtubule formation. This has been implicated to facilitate transport of 
lentiviral cores pseudotyped with MV gps towards the nucleus, and may also be important in 
trafficking of MV cores [23] (Figure 2). Whether this also refers to the intracellular transport of MV 
cores (which would then specifically apply to hematopoietic cells) has not been resolved.  
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Figure 2. The role of the cytoskeleton in MV replication. Wild-type MV enters into 
hematopoetic cells after binding to CD150 (or CD46, middle structure). Not yet shown to 
occur in response to MV interaction, CD46 and CD150 can activate actin remodeling, on 
ligation. Similarly, recX, when interacting with MV, promotes signals causing 
dephosphorylation of ezrin-radixin-moesin (ERM) proteins and cofilin, and thereby actin 
remodeling and microtubule formation (both in blue). Activation of cytoskeletal 
remodeling may facilitate MV entry and subsequent transport of MV cores (in brown) to 
perinuclear sites where MV replication occurs, which may rely on tubulin interaction of the 
replicase. Mechanisms of core transport towards the budding site are unclear, yet there is 
evidence that it involves vesicular trafficking pathways (sensitivity to Rab9 abrogation). 
The budding process itself is actin dependent, and barbed ends of actin filaments were 
detected in association with the nucleocapsid in budding virions by EM.  
 
 
Actin is packaged within MV virions, and suggesting a role of actin in virion formation, particle 
production is cytochalasin B and D sensitive [24,25]. As revealed at the ultrastructural level, MV 
budding at the plasma membrane shares similarities to generation of microvillar protrusions with 
regard to actin filament recruitment [26]. These observations corroborated earlier findings where the 
majority of MV structural proteins were found in association with the actin cytoskeleton in infected 
cells [27]. Interestingly, actin filaments were found to almost exclusively protrude with their barbed 
ends into virus particles in close association with the nucleocapsids indicating that MV budding 
involves vectorial growth of actin filaments. In vitro, actin was found associated with purified 
ribonucleoprotein complexes (RNPs), yet tubulin, rather than actin, co-precipitated with and was 
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required for the activity of the viral polymerase complex, indicating that cytoskeletal components are 
important at different steps of MV replication [28]. These observations were confirmed in studies in 
infected Vero cells, which did, however, not reveal targets in the MV replication cycle either [29]. 
Though likely to occur, microtubular trafficking of MV RNPs involving molecular motors such as 
dynein or kinesin within infected cells, especially neurons, has not yet been proven. Abrogation of MV 
release on Rab9 ablation from infected HeLa implies a role of vesicular trafficking pathway for the 
RNP [30,31] (Figure 2). Overall, the limited amount of data available suggest that, similar to that of 
related viruses (such as respiratory syncytial virus, RSV) [32], microtubules might play a dominant 
role in the formation and long distance transport of MV RNPs while actin plays a more prominent role 
in virus release.  
Given the importance of the cytoskeleton network for MV replication and release, it is not 
surprising that there is no evidence for disruption of the actin-, vimentin- or tubulin network in MV 
infected tissue culture cells [33]. Spatial alterations of cytoskeletal components such as intermediate 
and thin (actin) filaments observed in persistently MV infected cells were interpreted as relating  
to disturbances of RNP transport from assembly sites to the plasma cell membrane, and thereby 
to persistency. 
Because MV infects and relies on motile cells for dissemination, MV infection per se, for obvious 
reasons, does not grossly perturb cytoskeletal dynamics relating to the morphological front-rear 
polarization (including receptor segregation), acquisition of a motile phenotype and migration. In fact, 
MV infected DCs and lymphocytes were readily detectable in the majority of lymphoid compartments 
including the bone marrow in infected rhesus macaques [3,6]. In vitro, MV infection of immature DCs 
promoted phenotypic maturation resembling that driven by TLR4 ligation, and also enhanced 
Rac-dependent migration of these cells on fibronectin (FN) (mimicking extracellular matrix (ECM) 
interaction and 1-integrin ligation) [34]. Similarly, MV infection did not grossly affect chemokinesis 
of lymphocytes through filters, while transendothelial migration of these cells was efficiently 
abrogated [35], which related to integrin upregulation and activation promoting lymphocyte retention 
rather than interference with cytoskeletal rearrangement.  
3. MV Interference with T Cell Signaling and Activation 
Cytoskeletal rearrangements essentially govern any step of the formation of an IS where recognition 
of its cognate peptide/major histocompatibility (MHC) complex on the APC by the T cell receptor 
(TCR) triggers T cell activation, expansion and finally, differentiation. IS formation is preceded by 
trapping of T cells on the APC surface, which is followed by ameboid T cell migration for scanning for 
cognate MHC-peptide complexes, during which they retain their polarized morphology and 
longitudinal protein gradients, and continuously reorganize their lamellopodia at the leading edge. On 
antigen recognition, large scale rearrangements of the T cell occur, involving adhesion strengthening 
by leucocyte function antigen 1 (LFA-1) activation and T cell re-polarization by the segregation of an 
enlarged, flattened interface with the APC, to which the microtubule organizing center (MTOC) is 
translocated as well, and, opposite, the distal pole complex [36–38]. Rearrangements of receptors and 
signaling complexes as well as the formation of localized signaling clusters and their centripetal 
circulation involves actin cytoskeletal dynamics, which is accompanied by rapid 
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activation/de-activation of ezrin-radixin-moesin (ERM) proteins, which also promote cytoskeletal 
relaxation as important for conjugate formation [39,40]. In line with the importance of actin dynamics 
in this process, latrunculin terminates T cell activation as determined by loss of tyrosine-
phosphorylation, Ca-mobilization, and conjugate stability, within less than two minutes [41]. In 
conjugates involving B cells as APCs, the IS acquires a typical ‘bull’s eye’ architecture where central, 
peripheral and distal supramolecular activation clusters (SMACs) containing CD3/CD28, LFA-1 or 
CD43, respectively, can be discerned (cSMAC, pSMAC, dSMAC). In contrast, IS involving DCs are 
predominantly multifocal in that multiple domains concentrating signaling clusters are separated by 
LFA-1 enriched protrusions, thereby segregating the actual signaling domains [41,42].  
Sustained activation of tyrosine kinases, especially Zeta-chain-associated protein kinase 70 
(ZAP-70) and lymphocyte-specific protein tyrosine kinase (Lck), and Ras activation are essential for 
calcium mobilization and Nuclear factor of activated T-cells (NFAT) activation, while sustained 
activation of the phosphatidyl-inositol-3 kinase (PI3K) pathway provides membrane domains enriched 
for inositolpolyphosphates (phosphatidyl-inositol-3,4,5-phosphates, PIP3,4,5) which serve as docking 
sites for pleckstrin homology containing proteins such as the Akt kinase and major guanosine 
exchange factors regulating the activity of small GTPases of the Rho family [41,43]. More recently, 
semaphorin receptors and their ligands, known to activate GTPases and essentially control adhesion or 
repulsion by targeting integrin activation and function, have also been implicated in IS function [44]. 
Within the following sections, we will review how MV might regulate T cell activation independently 
of infection by interacting with surface receptors.  
Signaling of MV Entry Receptors Independently of Infection 
As alluded to above, both CD46 and CD150 are signaling molecules with the property of shaping 
the quality of lymphocyte responses, which has been extensively studied and reviewed (examples are 
[8,9,12,45]). Interestingly, both molecules also act as phagocytic receptors with the capacity of routing 
their cargo into degradative phagosomal compartments and to recruit autophagy-associated 
components [46,47]. Most likely, MV escapes from degradation because it uses these molecules 
(CD150 alone for wild-type strains, or both for attenuated strains) not only for binding but also for 
help in membrane fusion.  
A growing number of pathogens, also including human herpesvirus 6, adenovirus and certain 
Neisseria species, have chosen CD46, a non-raft molecule, as a receptor, and thus, consequences of 
ligation of this molecule on cellular functions has received much attention in the recent past [12]. 
CD46 acts to costimulate CD3 in primary human T cells to enhance activation of extracellular signal 
regulated kinase (ERK), but also to promote morphological alterations and actin relocalization towards 
the leading edge, compatible with front-rear polarization and acquisition of a motile phenotype [48]. 
Consistent with lamellopodia formation in these cells, CD46 ligation alone, and more pronounced on 
CD3 co-ligation, caused tyrosine phosphorylation of Vav and activation of the small GTPase Rac, yet 
not RhoA or Cdc42 (Figure 2). Obviously, CD46 cytoplasmic domain isoforms generated due to 
alternative splicing are differentially active in promoting Vav activation on ligation and this affected 
the degree of morphological alterations and substrate or homotypic adhesion [49]. Since CD46 
dependent regulation of cytoskeletal activity in these systems by antibodies were dependent on 
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crosslinking, it is likely that they would also occur on ligation by MV, which would, however, only 
refer to CD46 use and thereby attenuated strains. The same applies to a potential regulation of ERM 
protein family members by interaction with CD46. There, physical and functional association of 
moesin and CD46 in MV uptake were reported, yet the contribution of moesin in this process remained 
unclear and its activation status and association with the plasma cell membrane and actin cytoskeleton 
were not analyzed [50]. Though ERM proteins doubtlessly play an important role in cytoskeletal 
dynamics and receptor segregation in T cell activation [40,51], the importance of CD46 in regulating 
these molecules in this process in general or its role in modulation of T cell activation by wild-type 
MV has not yet been substantiated.  
As a member and type species of the SLAM family, CD150 (SLAMF1), apart from its role as 
receptor for MV and microbial sensor for certain gram-negative bacteria (see above), is a self ligand 
with a strong tendency for lateral self aggregation [8]. Specific adaptors (SLAM-associated protein 
(SAP) in T, NKT and some B cells, and Ewing Sarcoma Breakpoint region 1/Friend Leukemia Virus 
Integration-activated transcript 2 (EAT-2) in NK cells, DCs and macrophages) couple CD150 to 
downstream signaling pathways, which also include recruitment of FynT but also p21 activated kinase 
(PAK) interacting exchange factor (PIX) [52]. This suggests that CD150 signaling could indeed, via 
PAK activation, regulate cytoskeletal dynamics (Figure 2). This has, however, so far not been directly 
revealed, nor has any impact of CD150 ligation on T cell morphing been noted. Not yet verified to 
occur in T cells as well, CD150 can, on coupling to the 5'lipid phosphatase SHIP-1 (SH2-containing 
inositol phosphatase-1), activate ERK, and, independently of tyrosine phosphorylation and SHIP-1 
recruitment, Akt phosphorylation in B cells [53]. On ligation by antibodies, CD150 potentiated or even 
induced—in the absence of concomitant TCR engagement—cytokine release from human T cells or 
promoted cytotoxicity of CD8+ T cells collectively, rendering it an overall efficient T cell 
co-stimulator. Consequences of MV ligation for CD150 signaling are as yet unknown.  
4. MV Surface Interaction with T Lymphocytes: The Cytoskeletal Collapse and Role of 
Sphingomyelinase Activation 
Almost 15 years ago it became clear that surface interaction with the MV gp complex abrogated 
stimulated or—in cell lines—constitutive proliferation of hematopoietic cells [54]. This did not involve 
CD150 or CD46, membrane fusion, infection, apoptosis or release of soluble inhibitory factors.  
Rather, cells exposed to the MV gp complex on infected cells, cells transfected to express MV F/H 
proteins or inactivated virions, arrested in the G1 phase of the cell cycle associated with typical 
deregulation of cyclin dependent kinases and their inhibitors, provided the F protein was 
proteolytically activated [55–59]. Importantly, the MV gp complex also caused similar effects in 
experimentally infected cotton rats [60,61].  
On a molecular level, MV gp signaling was found to target activation of the PI3/Akt kinase 
pathway in response to IL-2R or TCR triggering [62] (Figure 3). Later, this was related to both delayed 
degradation of Cbl-b, or, generated by alternative splicing due to PI3K inhibition, a constitutively 
active SHIP-1 isoform, which continuously depleted the plasma membrane PIP3,4,5 pool thereby raising 
the threshold for activation [63,64]. Vav is a downstream effector of PI3K and, thus, MV signaling 
targeted TCR-dependent activation of Rac1 and Cdc42, yet not RhoA which was even slightly 
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activated on MV exposure. Indicating that MV contact abrogated actin cytoskeleton reorganization, the 
ability of T cells to adhere to and polarize on FN or -CD3/CD28 coated substrates was strongly 
impaired as was their ability to translocate the MTOC towards the IS and CD3 to the cSMAC in 
conjugates with lipopolysaccharide(LPS)-matured DCs [22].  
More recently, we were able to show that TCR-mediated IS recruitment of plexinA1 and 
neuropilin-1, a semaphorin receptor complex, which is involved in early IS formation and function, is 
also ablated in MV exposed T cells [65–67]. As evidenced in neuronal cells, translocation of these 
molecules and the activity of the signaling moiety, plexinA1, to regulate adhesion, involve cytoskeletal 
dynamics and integrin signaling, respectively [68]. PlexinA1/neuropilin-1 are expressed both on  
T cells and DCs, and thus, their effect to promote early IS functions may involve homotypic 
interaction, though heterotypic have not been excluded. Late after DC activation, soluble semaphorin 
3A (SEMA3A) is produced, which acts as a repulsive ligand promoting collapse of actin based 
structures, e.g., in neuronal growth cones, and this involves adaptor proteins also referred to as 
‘collapsins’ [69,70]. In line with its function in resolving cell contacts, SEMA3A production late after 
DC/T cell interaction has been related to termination of activation [71,72], and it is thus remarkable 
that in co-cultures of MV-infected DCs and T cells, this repulsive semaphorin receptor ligand is 
produced already within the first hours. Recombinant SEMA3A (and SEMA6A) caused a marked 
transient loss of cellular actin and actin based protrusions, yet only moderately affected DC/T cell 
conjugate stability and efficiency in vitro [67,72], and thus, the role in regulating IS functions and 
potential modulations thereof by viruses remains to be established. Semaphorin production may, 
however, not essentially contribute to the instability of conjugates formed between MV-infected DCs 
and T cells. The majority of conjugates observed in these co-cultures resolved within less than two 
minutes and only allowed for a transient Ca-burst instead of sustaining both the cell contact and  
Ca-mobilization as required for T cell activation. Indicating that again the MV gp complexes 
essentially accounted for loss of IS stability, this was largely rescued when DCs infected with a 
recombinant MV expressing VSV G protein instead were used in conjugate formation [34].  
MV exposure does not only affect stimulated cytoskeletal rearrangements, yet causes a loss of actin 
based microvillar structures from T cells, and this was accompanied by a loss of ERM protein 
phosphorylation [22] (Figure 3). These observations, together with RhoA activation and PI3K 
interference (see above) were consistent with those made mainly in non-T cells after activation of 
spingomyelinases (SMases). These differ in their respective pH optimum, and their activity largely 
accounts for accumulation of membrane ceramides; that of the acid sphingomyelinase (ASM) 
catalyzes the transformation of small membrane cholesterol and sphingomyelin (SM) enriched 
microdomains (also referred to as rafts) into large, ceramide-enriched membrane platforms in response 
to a variety of external stimuli [73,74]. In hematopoietic cells, these include ligation of death receptors 
CD40, FcRII and CD28 [75,76]. Pathogens such as P. aeruginosa, S. aureus and rhinovirus promote 
and rely on formation of ceramide-enriched platforms for entry (reviewed in [75]) while 
fusion-dependent uptake of HIV is prevented on ceramide accumulation [77,78]. Ceramide enriched 
platforms regulate lateral diffusion and recruitment of surface receptors and membrane-proximal 
signaling complexes, thereby enhancing initiation or modulating signaling pathways including 
PI3K [79,80]. SMase activation was also implicated in cytoskeletal remodeling in breast cancer  
MCF-7 cells [81,82]. There, cisplatin induced ASM activation and subsequent sphingomyelin 
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breakdown in the outer membrane bilayer promoted a protein phosphatase 2A (PP2A)-dependent loss 
of ERM protein phosphorylation and of actin based protrusions.  
Figure 3. MV signaling via receptorX causes T cell actin cytoskeletal paralysis. On 
binding to recX, the MV gp complex (consisting of the proteolytically activated F1/2 
heterodimer and the H protein) signals to abrogate PI3K activation, e.g., in response to 
TCR ligation (CD3/CD28), which causes inactivation of downstream effectors such as Akt 
kinase, Vav and Rac1/Cdc42. To a major extent, PI3K interference is mediated by 
sequential activation of neutral (NSM) and acid sphingomyelinase (ASM), which promotes 
surface translocation of ASM and subsequent breakdown of outer membrane 
sphingomyelin (SM) and formation of ceramide (Cer)-enriched membrane microdomains. 
ASM activation and ceramide accumulation have been linked to abrogation of ERM 
phosphorylation, RhoA activation and PI3K interference and loss of actin based 
protrusions in non-lymphoid cells. In T cells, ceramide induction by MV or recombinant 
bacterial sphingomyelinase has been directly linked to the MV (bottom panels) loss of actin 
cytoskeletal dynamics as evidenced by loss of actin and receptor polarization, microvillar 
protrusions or lamellopodial structures on substrates mimicking the ECM (such as 
fibronectin, bottom right panels, where actin is detected by phalloidin (green), the arrow 
marks the leading edge in MOCK treated cells) or the immunological synapse 
(CD3/CD28 coated slides, bottom left panels; the upper panel shows two interacting 
MOCK treated T cells). Whether ceramide accumulation also directly accounts for 
MV-dependent inhibition of IS formation or T cell activation is as yet unknown (therefore 
indicated in italics).  
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Indeed, MV exposure was found to sequentially activate NSM and ASM in T cells, and this 
accounted for the general loss of actin cytoskeletal dynamics in these cells [83] (Figure 3). Thus, 
pharmacological or genetic ablation of SMase activation essentially restored the ability of MV exposed 
T cells to polarize and spread on substrates, segregate receptors, migrate in response to stromal cell 
derived factor 1 (SDF-1) and to retain actin-based microvillar protrusions. In turn, exogenous ceramide 
accumulation caused loss of polarity and ezrin, yet not moesin phosphorylation on stimulation 
indicating that SMAse activation in general acts to regulate T cell activation by modulating 
cytoskeletal dynamics.  
5. Outlook: SMase Activation in Immune Cells—Is There More to It? 
As outlined above, SMase activation in response to receptor triggering may promote receptor 
clustering favoring subsequent internalization [73,75]. Because lateral concentration of viral receptors 
has been proposed to be one of the principles underlying enhancement of viral DC infection by 
DC-SIGN [84], we addressed the possibility that SMase activation could play a role in this process. 
Indeed, ligation of DC-SIGN by antibodies, mannan or MV caused activation of both NSM and ASM 
within few minutes and subsequent outer membrane display of ceramides [85]. SMase activation was 
found to be essential for membrane proximal relay of DC-SIGN signaling as reflected by abrogation of 
Raf-1 and ERK-1/2 phosphorylation known to occur in response to DC-SIGN ligation [86–88] by 
SMase inhibitors, but also for promoting enhancement of MV uptake into DCs. This was linked to 
SMase-dependent translocation of CD150 from intracellular storage compartments for transient 
membrane display [85]. Though not analyzed to occur in DCs, HIV fusion mediated uptake was found 
to be inhibited rather than enhanced by accumulation of membrane ceramides because this interfered 
with lateral CD4/chemokine receptor co-segregation [77,78,89]. It is tempting to speculate that—in 
case HIV would also cause DC-SIGN dependent SMase activation there—lateral segregation of its 
entry receptors on DCs might favor enhancement of internalization and storage of viral particles for 
subsequent trans-infection of T cells. Thus, SMase activation by attachment receptor interaction might 
be highly relevant for the mode of viral uptake into DCs and subsequent delivery to T cells and thereby 
viral pathogenesis. 
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